Managing Acute Respiratory Distress Syndrome

This update of a 2017 clinical practice guideline addresses use of steroids and neuromuscular blockade for ARDS patients.

Sponsoring Organization: American Thoracic Society (ATS)

Background

Acute respiratory distress syndrome (ARDS) is a form of hypoxemic respiratory failure with high mortality. The mainstays of therapy are supportive and are designed to minimize further lung injury from mechanical ventilation. With the large number of patients with ARDS during the early COVID-19 pandemic, new data supports some revisions to standard care of patients with ARDS. The ATS has now released an update of its 2017 guideline, originally published in association with the European Society of Intensive Care Medicine and the Society of Critical Care Medicine (Am J Respir Crit Care Med 2017; 195:1253).

Key Points

Administration of steroids is recommended, although without spec…

Reviewing Author

Patricia Kritek, MD

Disclosures

Editorial BoardsATS Scholar

Patricia Kritek, MD

Disclosures

Editorial BoardsATS Scholar

Managing Acute Respiratory Distress Syndrome

Topics

Background

Key Points

Reviewing Author